https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1528204/full
Frontiers | Case report: Cerebrotendinous Xanthomatosis masquerading as adult ADHD in psychiatric...
IntroductionThis case report details the presentation of a patient who initially sought consultation at a psychiatric outpatient clinic with symptoms suggest...
case reportadult adhdfrontiers
https://pubmed.ncbi.nlm.nih.gov/33704661/
Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease caused by deficiency of sterol 27-hydroxylase enzyme encoded by CYP27A1 gene. This multicenter,...
patientsdiagnoseddiversemultisysteminvolvement
https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-cerebrotendinous-xanthomatosis-rare-lipid-storage-disease
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease | FDA
The FDA approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a...
fda approvestreatment for